General Information


DRAVP ID  DRAVPe02160

Peptide Name   Octapeptide

Sequence  AVLQSGFR

Sequence Length  8

UniProt ID  P0C6U8 

Taxon ID  694009 

Source  Structure of SARS-CoV Mpro

Validation   Experimentally Validated



Origin Information


Gene Name/ID  1a

GenBank  Not Available

Amino Acid position  Not Available

Domain Accession ID  Not Available

Nucleotide sequence ID  Not Available

Molecular Type  Not Available

Chromosomal Position  Not Available



Activity Information


Target Organism  SARS-CoV

Assay  Cell–Cell Fusion Assay

Activity 

  • [Ref:16242214]HCoV-229E,IC50=0.5μM(pseudotyped),1.7μM(livevirus)

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • [Ref:16242214]no detectable toxicity is observed on Vero cells .100

Binding Target  Not Found

Mechanism  It inhibits replication



Structure Information


PDB ID  None

Predicted Structure Download  No predicted structure available

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C39H64N12O11

Absent amino acids  NDCEHIKMPTWYOU

Common amino acids  ARQGLFSV

Mass  877.01

Pl  9.79

Basic residues  1

Acidic residues  0

Hydrophobic residues  8

Net charge  1

Boman Index  1.1

Hydrophobicity  0.425

Aliphatic Index  97.5

Half Life 

  •     Mammalian:4.4 hours
  •     Yeast:>20 hour
  •     E.coli:>10 hours

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  6



Literature Information


Literature 1

Title   Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase

Pubmed ID   16242214

Reference   Peptides, 27(4), 622–625.

Author   Gan, Y. R., Huang, H., Huang, Y. D., Rao, C. M., Zhao, Y., Liu, J. S., Wu, L., & Wei, D. Q. (2006).

DOI   10.1016/j.peptides.2005.09.006